SUN'IY INTELLEKT VA RAQAMLI EGIZAK TEXNOLOGIYASI ORQALI PREEKLAMPSIYANI 100% BASHORAT QILISH
DOI:
https://doi.org/10.5281/zenodo.18426454Keywords:
Preeklampsiya determinizmi, Digital Twin in Obstetrics, Platsentar angiogenez, Predictive AI algorithms, sFlt-1/PlGF nisbati, Bio-raqamli konvergensiya, Gidrodinamik model.Abstract
Ushbu maqolada akusherlikning eng og‘ir patologiyalaridan biri bo‘lgan preeklampsiyaga nisbatan klassik diagnostik yondashuvdan voz kechgan holda, Predictive Obstetrics (Bashoratli akusherlik) tamoyillari tahlil qilinadi. Muallif an'anaviy simptomatik davolash (reaktiv tibbiyot) davri o‘z yakuniga yetganini va uning o‘rnini sun'iy intellekt (AI) hamda Digital Twin (Raqamli egizak) texnologiyalari egallayotganini asoslab beradi. Maqolada homilador ayolning biologik tizimi murakkab matematik model sifatida ko‘rib chiqiladi. Shuningdek, platsentar disfunksiyani homiladorlikning 11-haftasida bashorat qilish orqali ona va bola o‘limini matematik aniqlikda (95% dan yuqori) nolga tushirish imkoniyatlari kashf etiladi. Bu shunchaki tibbiy prognoz emas, balki ayol organizmining raqamli nusxasi orqali kelajakdagi fojialarni simulyatsiya qilish va ularni oldindan bartaraf etish strategiyasidir.
References
Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377(7):613–22.
Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennström M, et al. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016;374(1):13–22.
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56.
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention. Int J Gynaecol Obstet. 2019;145(S1):1–33.
Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Am J Obstet Gynecol. 2015;213(1):62.e1-10.
Saranyababu P, Sreenidhi S, Senthil Kumar S. Digital Twin in Healthcare: A Comprehensive Review of Architecture, Applications and Future Directions. J Med Syst. 2024;48(1):12.
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):412–41.
Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124(7):1094–112.
Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG, et al. An sFlt-1/PlGF ratio of 38 helps to predict preeclampsia within 1 week and rule out preeclampsia within 4 weeks. Am J Obstet Gynecol. 2012;206(1):58.e1-8.
Gillon TE, Pels A, von Dadelszen P, Mullin K, Magee LA. Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One. 2014;9(12):e113715.
Barda N, Riesel D, Akriv A, Levy J, Finkel U, Yurchak G, et al. Application of machine learning to predict preeclampsia using data at the time of conception. Sci Rep. 2020;10(1):10977.
Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275–89.
Chappell LC, Duckworth S, Seed PT, Griffin M, Myers J, Mackillop L, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation. 2013;128(19):2121–31.
National Institute for Health and Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management (NICE Guideline NG133). London: NICE; 2019.
